/Biogen%20Inc%20logo%20on%20HQ-by%20Tada%20Images%20via%20Shutterstock.jpg)
Biogen has significantly underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
/Biogen%20Inc%20magnified-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Biogen has lagged well behind the broader market over the past year, yet analysts maintain a fairly optimistic outlook on its future performance.
/NVR%20Inc_%20phone%20and%20website%20by-%20T_Schneider%20via%20Shutterstock.jpg)
Over the past year, NVR has delivered performance that surpasses the broader market. However, Wall Street analysts are cautious about its growth outlook.
Biogen has significantly underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
/Lennar%20Corp_%20phone%20and%20webpage%20by-%20Wirestock%20Creators%20via%20Shutterstock.jpg)
Lennar has significantly outperformed the broader market over the past year, yet analysts are moderately bullish on the stock's outlook.
/Biogen%20Inc%20logo%20on%20laptop-by%20monticello%20via%20Shutterstock.jpg)
Despite Biogen’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately bullish about the stock’s prospects.